Obalon Therapeutics Competitors and Similar CompaniesClear all

Obalon Therapeutics's competitors and similar companies include Implandata Ophthalmic Products, Tactile Medical, UroMems and AdaptHealth.

	Obalon Therapeutics Obalon Therapeutics offers gastric balloon technology that assists weight loss by inducing a feeling of fullness.	Implandata Ophthalmic Products Implandata Ophthalmic Products is a digital health company offering products and solutions for glaucoma patients.	Tactile Medical Tactile Medical is advancing the standard of care in treating chronic diseases at home.	UroMems UroMems is focuses on designing, developing and commercializing active implantable medical devices.	AdaptHealth AdaptHealth a full-service home medical equipment and respiratory company offering a breadth of clinically-focused products and services.
Founding Date	Founding Date 2008	Founding Date 2010	Founding Date 2006	Founding Date 2011	Founding Date 2012
Type	Type Public	Type Private	Type Public	Type Private	Type Public
Tags	Tags Healthcare healthtech medical devices therapy	Tags Healthcare healthtech medical devices therapy	Tags Healthcare healthtech medical devices therapy	Tags Healthcare healthtech medical devices therapy	Tags Healthcare healthtech medical devices therapy
Locations	Locations Carlsbad, US HQ	Locations Hannover, DE HQ	Locations Minneapolis, US HQ	Locations Grenoble, FR HQ	Locations Conshohocken, US HQ Phoenixville, US
Employees	Employees 294% decrease	Employees 12	Employees 62926% increase	Employees N/A	Employees 2,6011% increase
Valuation ($)	Valuation ($) 30.6 m	Valuation ($) N/A	Valuation ($) 346.8 m	Valuation ($) N/A	Valuation ($) 1.5 b
Financial
Revenue (est.)	Revenue (est.) $319.7k (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $329.5m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $3.2b (FY, 2025)
Cost of goods	Cost of goods $100.9k (FY, 2025)	Cost of goods N/A	Cost of goods $79.4m (FY, 2025)	Cost of goods N/A	Cost of goods $2.6b (FY, 2025)
Gross profit	Gross profit $218.8k (FY, 2025)	Gross profit N/A	Gross profit $250.1m (FY, 2025)	Gross profit N/A	Gross profit $609.2m (FY, 2025)
Net income	Net income ($10.5m) (FY, 2025)	Net income N/A	Net income $19.1m (FY, 2025)	Net income N/A	Net income ($66m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 20m	Total funding raised $ 7.7m	Total funding raised $ 23.2m	Total funding raised $ 32.6m	Total funding raised N/A